Edwards Lifesciences - Stock Price History | EW

Historical daily share price chart and data for Edwards Lifesciences since 2022 adjusted for splits. The latest closing stock price for Edwards Lifesciences as of October 03, 2022 is 85.46.
  • The all-time high Edwards Lifesciences stock closing price was 130.68 on December 30, 2021.
  • The Edwards Lifesciences 52-week high stock price is 131.73, which is 54.1% above the current share price.
  • The Edwards Lifesciences 52-week low stock price is 81.87, which is 4.2% below the current share price.
  • The average Edwards Lifesciences stock price for the last 52 weeks is 107.02.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Edwards Lifesciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 102.6415 88.9200 130.6800 78.6800 129.5500 42.00%
2020 76.0899 77.5000 91.2300 52.4100 91.2300 17.32%
2019 66.6031 49.7467 82.0867 47.8867 77.7633 52.31%
2018 47.4304 37.1933 58.0333 37.1933 51.0567 35.90%
2017 35.6791 31.8400 40.0500 29.8300 37.5700 20.29%
2016 33.0329 26.2800 40.4533 24.8400 31.2333 18.64%
2015 23.7968 21.2867 27.5200 20.6433 26.3267 24.01%
2014 15.2930 10.9867 22.2467 10.6950 21.2300 93.70%
2013 12.3299 15.3567 15.7600 10.2400 10.9600 -27.07%
2012 14.6319 12.0000 18.2917 11.4050 15.0283 27.54%
2011 13.1879 13.2083 15.2267 10.4167 11.7833 -12.54%
2010 9.4683 7.2892 14.1250 7.1508 13.4733 86.16%
2009 5.5525 4.6658 7.3150 4.4267 7.2375 58.05%
2008 4.4329 3.7667 5.5142 3.5492 4.5792 19.48%
2007 4.1140 3.9950 4.3967 3.8300 3.8325 -2.23%
2006 3.7172 3.4500 4.0258 3.4458 3.9200 13.05%
2005 3.5776 3.3958 3.8967 3.2892 3.4675 0.85%
2004 2.8796 2.4950 3.5217 2.4675 3.4383 37.16%
2003 2.3694 2.1317 2.7100 2.0367 2.5067 18.10%
2002 2.1208 2.2833 2.4608 1.5475 2.1225 -7.82%
2001 1.9118 1.4483 2.3967 1.4067 2.3025 55.66%
2000 1.5646 1.3750 2.1875 1.0833 1.4792 0.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $51.226B $5.233B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $198.711B 20.24
Alcon (ALC) Switzerland $28.513B 24.14
STERIS (STE) Ireland $16.630B 20.66
Teleflex (TFX) United States $9.450B 15.06
Fresenius Medical Care AG KGaA (FMS) Germany $8.228B 7.59
Penumbra (PEN) United States $7.184B 861.82
Globus Medical (GMED) United States $5.928B 30.24
Glaukos (GKOS) United States $2.520B 0.00
Integer Holdings (ITGR) United States $2.061B 16.12
Nevro (NVRO) United States $1.649B 0.00
Paragon 28 (FNA) United States $1.368B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.031B 15.78
Artivion (AORT) United States $0.558B 53.23